Bandingkan Harga & Kinerja Jakarta International Hotels Development Tbk (JIHD) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Jakarta International Hotels Development Tbk dan Brigit Biofarmaka Teknologi Tbk.: Jakarta International Hotels Development Tbk diperdagangkan di Rp450 (kapitalisasi pasar 1,05 T, volume 24 jam 73,6 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Jakarta International Hotels Development Tbk jauh lebih besar — sekitar 6,3× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (324 rb vs 73,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| JIHD | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 1,05 T | 166,01 M |
Volume | 73,6 rb | 324 rb |
Lot | 736 | 3,24 rb |
Perputaran | 33,02 jt | 77,68 jt |
Harga Rata-rata | 448,66 | 239,75 |
Nilai Transaksi | 33,02 jt | 77,68 jt |
Harga Ekuilibrium Indikatif | — | 240 |
Volume Ekuilibrium Indikatif | — | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Jakarta International Hotels Development Tbk
PT Jakarta International Hotels and Development Tbk (the Company) was established on November 7, 1967. The Company is the owner of Hotel Borobudur (“the Hotel”) which had been managed and operated by Inter-Continental Hotels (Indonesia) BV (Operator) until December 31, 1998. Starting January 1, 1999, the Hotel has been operated by PT Dharma Harapan Raya 60% of whose shares are owned by the Company.
Selengkapnya di halaman JIHD →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
